
Opinion|Videos|November 25, 2024
Updated Phase III MIRASOL Trial Results: Mirvetuximab Soravtansine vs Chemotherapy in Platinum-Resistant Ovarian Cancer with High Folate Receptor-Alpha Expression
Dr Coffman breaks down the findings from the phase III MIRASOL trial, and provides insight surrounding the treatment options and potential clinical implications surrounding ovarian cancer treatment.
Advertisement
Episodes in this series

Now Playing
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Top 5 women's health headlines you missed in October 2025
2
Postpartum complications common in first year after birth
3
Step count tied to lower mortality and heart disease risk in older women
4
Natasha Spencer, MD, highlights advances in obstetric management
5












